EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
Posted: Sat Apr 08, 2006 8:24 pm Post subject: Minocycline and Neuroprotection
Yes Arron and Viper-- that's the million dollar/pound question.
In addition to the MMP action Arron pointed out, that is similar to lipoic acid as NHE noted, here are some other broad "indicators" that minocycline may be quite neuroprotective.
To date, minocycline has been demonstrated to have a benefical effect in a wide variety of models of neuropathological conditions, including brain and spinal cord trauma, hemorrhagic stroke, Parkinson’s disease (PD), multiple sclerosis (MS), ALS, Huntington’s disease (HD), Alzheimer’s disease (AD), neonatal hypoxia-ischemia, ototoxicity, glaucoma, HIV, encephalopathy, prion disease and pain. Phase III clinical trials of minocycline are in process for MS, ALS and PD.
As a neuroprotective agent, the drug appears more effective than other treatment options. In addition to its high penetration of the blood-brain barrier, minocycline is a safe compound commonly used to treat chronic infections. Its several mechanisms of action in neuroprotection-antiinflammatory and antiapoptotic effects, and protease inhibition-make it a desirable candidate as therapy for acute neurologic injury, such as ischemic stroke. Minocycline is ready for clinical trials of acute neurologic injury.
Various experimental animal investigations suggest that potential therapeutic agents include estrogen, progesterone, minocycline, erythropoietin, and magnesium.
Notice I didn't emphasize estrogen and progesterone. In the absence of a definite "cause" of MS, I lean toward neuroprotection, but it would be really nice to know what's what. Let's hope someone has that on their research agenda.
Joined: Jun 18, 2004 Posts: 1459 Location: Bedfordshire UK
Posted: Mon Apr 10, 2006 7:27 am Post subject:
Now, Viper, I was taking doxycycline and azithromycin, both neuro-protective for certain, but this neuro-protection would not be enough to suddenly make my progressive MS stop dead in its tracks and give me the amount of recovery which then ensued. I have had no new disease activity since starting treatment, which is not the normal course of events for SPMS. I now only take "booster doses" of these antibiotics plus five days of tinidazole for two weeks every two months or so. In between times I take nothing. One might think that the neuro-protective effect of the antibiotics would wear of in that period, but in actual fact, I feel no difference between when I am taking them and when I am not, apart from the fact that in the five days I am taking tinidazole I feel marginally more fatigued and slightly depressed. This tends to happen with that particular drug, even more so with flagyl. So would I swap to Paratek? Absolutely not because I want more than just neuro-protection. I want to be free of a disease which left me unable to use my right arm and therefore unable to paint (my profession) when I was only in my prime. So I will stick with the cheap, readily available, out of patent antibiotics because they gave me back my life.
Sarah
edit: Hello Sharon, I wasn't ignoring you - you just snook in while I was typing _________________ An Itinerary in Light and Shadow
Completed Stratton/Wheldon antibiotic regime for aggressive secondary progressive MS in June 2007, after four years. Still slowly improving with no exacerbation since starting. EDSS was 7, now 2 or often less.
I'm jumping back in way down the thread from when this was mentioned, but I'm confused. When was there a copaxone + minocycline trial where the antibiotic only was administered to people? I followed the link to the Canadian study on minocycline, but is this the same as the copaxone + minocycline study you were talking about? Did the Canadian human study ever get published in a journal?
Joined: Feb 02, 2004 Posts: 863 Location: California, USA
Posted: Wed Apr 12, 2006 5:04 pm Post subject:
hi Lisa,
there was a minocycline only trial, which led to (?) the Copaxone + minocycline trial. I have not seen the results of that trial, nor do I know whether they compared it to antibiotics only, Copaxone only, or placebo. _________________ Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.
The study that just used minocycline (and then added copaxone for its phase II) was published in Annals of Neurology, May 2004. I happen to have contacted the researcher who had so many inquiries that she put together a PDF document on her findings and on using minocycline off label. Unfortunately, being PDF, and very long, I can't post, but anyone interested can PM me with an email address and I'll forward the document.
Joined: Feb 02, 2004 Posts: 863 Location: California, USA
Posted: Thu Apr 13, 2006 1:48 am Post subject:
ljm, if you send the file to me (arron AT thisisms.com) I'll post it in the resources section so you won't have to keep fielding e-mails. _________________ Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.
Done. If there is any problem posting this document without permission then please advise and I can go back to emailing out directly to anyone who requests.
Joined: Feb 02, 2004 Posts: 863 Location: California, USA
Posted: Thu Apr 13, 2006 1:00 pm Post subject:
Thanks...I'll take a look and see If they were willing to send it out to people publicly, then it should be OK. _________________ Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.
All times are GMT - 6 Hours Goto page Previous1, 2
Page 2 of 2
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
Forum FAQ
Search
Usergroups
Profile
Log in to check your private messages
Log in
In the absence of a definite "cause" of MS, I lean toward neuroprotection, but it would be really nice to know what's what. Let's hope someone has that on their research agenda.
If they were willing to send it out to people publicly, then it should be OK.